Ampath launches its pathology laboratory in Chandigarh 

Chandigarh, October 20, 2021: AMPATH launched its Pathology Laboratory in Chandigarh for citizens to experience superior, accurate, fast and affordable world class lab services. Present at the event were Dr. Vijay Kumar Vemuri – Group COO – CTSI, Mr. Atul Rastogi – CFO & Head of Control Functions (VP) , Dr. Mukesh Agrawal – Lab Director Ampath along with other dignitaries.  
AMPATH (American Institute of Pathology and Laboratory Sciences Pvt. Ltd.), is a fully automated pathology and diagnostic solution provider operating with a  comprehensive list of pathology tests ranging from Routine tests menu to Esoteric to high-end molecular diagnostic tests, to meet the changing needs of India's dynamic healthcare market. 
Commenting on the launch, Dr. Mukesh Agrawal - Lab Director, said, “Our lab is equipped to deliver quality pathology services to the people of Tricity. We are also actively involved in campaigns focused on creating awareness of conditions such as lifestyle diseases, monsoon diseases, and the importance of periodic health check-ups,” he added. This lab will offer Microbiology & Molecular testing as well. 
Dr. Jagprag Singh Gujral, Group CEO - South Asia, CTSI, commented, “It is with great pleasure that we launch our first Pathology Lab in Chandigarh for citizens and healthcare professionals to access world class, benchmarked pathology services. We are delighted that the growing network of Ampath will now be able to serve the population of Chandigarh with its automated and best in class, advanced test profile and quality standards. With the new addition in Chandigarh, Ampath now has an exhaustive presence covering more than 20 states across the subcontinent. CTSI, through its network of 16 Cancer Hospitals in South Asia, American Oncology Institute (AOI), Multispecialty-Citizens Specialty Hospital and chain of specialty diagnostic laboratories- Ampath is at the forefront of providing outcome focused healthcare services in South Asia.” 
Dr. Vijay Kumar Vemuri, Group Chief Operating Officer, CTSI, said, “We are excited to announce the launch of our Pathology Lab in Chandigarh. AmPath's clinical team has been trained in India, the UK, and the US to provide the best-in-class diagnostic services to the public.  
Currently, AMPATH has 9 existing Labs, 1700+ clients & 3 upcoming Labs in India, with approx. 2450 tests and profiles conducted. It delivers an entire spectrum of advanced diagnostic services emphasizing on quality, ethics, innovation, and best-in-class laboratory practices with reliable performance.